Trial intelligence / Profile preview

Patient Satisfaction With Propofol for Outpatient Colonoscopy

NCT02937506Phase 4Completed

Sponsor
Mount Carmel Health System
Start
Nov 2013
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of propofol in colon cancer, irritable bowel syndrome (IBS) and colonic polyps (2 arms), sponsored by Mount Carmel Health System. Primary endpoint: Patient Satisfaction at Day 0. Started Nov 2013; status: completed.

02

Drugs

propofol
03

Conditions

colon cancerirritable bowel syndrome (IBS)colonic polyps

Beyond the preview

Go deeper on NCT02937506.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02937506.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call